Podium Abstract
Eposter Presentation
 
Accept format: PDF. The file size should not be more than 5MB
 
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
 
Withdrawn
Abstract
A Refined Histopathologic Analysis for pT3b Prostate Cancer: Clinical Implications for Customized Surgical Design
Podium Abstract
Clinical Research
Oncology: Prostate
Author's Information
5
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Korea (Republic of)
Sungun Bang bbsungun@yuhs.ac Yonsei University College of Medicine Seoul Korea (Republic of) *
Jinhyung Jeon jun1644@yuhs.ac Yonsei University College of Medicine Seoul Korea (Republic of) -
Do Kyung Kim dokyung80@yuhs.ac Yonsei University College of Medicine Seoul Korea (Republic of) -
Jong Kyou Kwon jkstorm@yuhs.ac Yonsei University College of Medicine Seoul Korea (Republic of) -
Kang Su Cho kscho99@yuhs.ac Yonsei University College of Medicine Seoul Korea (Republic of) -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Abstract Content
Seminal vesicle invasion (SVI) is a high-risk factor for prostate cancer. SVI is observed in various patterns, yet no standardized method exists for evaluating its extent. Therefore, we analyzed the clinical characteristics of pT3b prostate cancer and conducted a refined histopathologic analysis of seminal vesicle (SV) specimens to closely examine the extent and pattern of SVI and assess its clinical implications.
A single surgeon’s database on robotic radical prostatectomy from July 2020 to December 2024 was retrospectively reviewed, identifying 73 patients staged as pT3b. Preoperative clinicopathological data and image review was performed. A refined histopathologic analysis was conducted to assess the presence of SV stromal invasion, peri-SV soft tissue involvement, and the surgical margin status of peri-SV soft tissue. The number of harvested and positive lymph nodes (LN) was also examined.
Among the 73 patients, 35 (47.9%) were clinically staged as cT3b, while the remaining 38 patients were preoperatively diagnosed as cT3a or lower. Prostatectomy specimens revealed bilateral SVI in 33 patients (45.2%). Notably, peri-SV soft tissue invasion was observed in 54 patients (74.0%), among whom clear surgical margins were secured in 49 (90.7%), while 5 (9.3%) had positive margins. Vas deferens invasion was present in 25 patients (34.2%). After excluding 7 patients who had received preoperative antiandrogen therapy and 8 who had not undergone pelvic lymph node dissection (PLND), 58 patients remained for analysis of PLND. The mean number of harvested LNs was 15.46 (3 – 34), and the mean number of involved LNs were 1.06 (0 – 16). Among the 58 patients, 25 (43.1%) had LN metastasis. Gleason grade group 4 or 5, peri-SV soft tissue invasion, vas deferens invasion and lymphovascular invasion were significantly associated with pelvic LN metastasis (p = 0.011, 0.043, p = 0.024, and p < 0.001, respectively).
In pT3b patients, the high rate of peri-SV soft tissue involvement highlight the thorough completeness of tumor removal, including meticulous resection of peri-SV soft tissue.
prostate cancer, seminal vesicle invasion, robotic prostatectomy, peri seminal vesicle tissue, lymph node metastasis
 
 
 
 
 
 
 
 
 
 
2101
 
Presentation Details
 
 
 
0